Sanjay Chanda - Concepedia

Author

Sanjay Chanda

Also Known As

Chanda, S., Chanda, Sanjay, Dr. Swarnava Chanda, S Chanda, S. Chanda, S. M. Chanda, Sanjay Chanda, Shreya Chanda, Stephanie Chanda

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Louisiana at Monroe NeuroBioTex (United States)Covance (United States)L V Prasad Eye Institute MPI Research (United States)

About

Sanjay Chanda is an author at University of Louisiana at Monroe specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	710
2	Health Sciences	3	3	206
3	Biochemistry	2	2	78
4	Engineering	1	1	117
5	Allergy	1	1	92

Sanjay Chanda

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain Sunita Babbar, Jean‐Francois Marier, Samer Mouksassi, Therapeutic Drug Monitoring Pain TherapyPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2009	136
In Vitro Hepatic and Skin Metabolism of Capsaicin Sanjay Chanda, Bashir Mohammad, Sunita Babbar, Drug Metabolism and Disposition	2008	131
Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Raja S. Mangipudy, Sanjay Chanda, Harihara M. Mehendale Environmental Health Perspectives EngineeringThioacetamide HepatotoxicityImmunologyTranslational MedicineTissue Repair Response	1995	117
Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality Sanjay Chanda, Raja S. Mangipudy, Alan Warbritton, Hepatology Apap LethalityApap DispositionPharmacotherapyExperimental PharmacologyOxidative Stress	1995	92
17β-Estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-α pathway Sanjay Chanda, Carole Robinette, John F. Couse, American Journal of Physiology-Endocrinology and Metabolism	2000	78
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study Lee T. Zane, Leon Kircik, Robert S. Call, Pediatric Dermatology	2016	77
Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open‐Label Phase 2a Study Wynnis L. Tom, Merrie Van Syoc, Sanjay Chanda, Pediatric Dermatology	2016	72
Differential modulation of organophosphate‐sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos J. Chaudhuri, T. K. Chakraborti, Sanjay Chanda, Journal of Biochemical Toxicology	1993	65
Hepatocellular Regeneration: Key to Thioacetamide Autoprotection Raja S. Mangipudy, Sanjay Chanda, Harihara M. Mehendale Pharmacology & Toxicology	1995	60
Comparative developmental and maternal neurotoxicity following acute gestational exposure to chlorpyrifos in rats Sanjay Chanda, Paul R. Harp, J. Liu, Journal of Toxicology and Environmental Health	1995	60

Page 1